The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.

[1]  A. Fischman,et al.  Biological target volume (BTV) determined with dose response data from the correlation between metabolic rate of glucose (MRG) measured with 18F-FDG PET and pathologic complete response (PCR) in stage III non-small cell lung cancer (NSCLC) , 2000 .

[2]  J A Patton,et al.  Coincidence imaging with a dual-head scintillation camera. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  M. Martel,et al.  Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[4]  F. Gherlinzoni,et al.  Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. , 1996, Haematologica.

[5]  J. R. Stewart,et al.  Radiation injury to the heart. , 1995, International journal of radiation oncology, biology, physics.

[6]  R. Mirimanoff,et al.  Comparison of treatment techniques for lung cancer. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  V. Lowe,et al.  Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. , 1996, American Journal of Clinical Oncology.

[8]  N. Gupta,et al.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small ( 3 cm) lymph node lesions. , 2000 .

[9]  Fluoroscopic real-time tumor-tracking radiation treatment (RTRT) can reduce internal margin (IM) and set-up margin (SM) of planning target volume (PTV) for lung tumors , 2000 .

[10]  H. Groen,et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.

[11]  T G Turkington,et al.  Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. , 1999, Lung cancer.

[12]  K Schnabel,et al.  18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.

[13]  Y. Ung,et al.  Fusing 18flourodeoxyglucose (FDG)-hybrid PET to CT images significantly alters treatment planning in the radical treatment of non-small cell carcinoma of the lung , 2000 .

[14]  H N Wagner,et al.  Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  T. Landberg,et al.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  M. Kris,et al.  Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  L. Rutqvist,et al.  Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  R. Coleman,et al.  PET in lung cancer. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  J. Hayman,et al.  Preliminary results of 92.4 Gy or more for non-small cell lung cancer , 2000 .

[20]  R L Wahl,et al.  Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. , 1999, Radiology.

[21]  Gerald J. Kutcher,et al.  The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer , 2000 .

[22]  John E. Connolly,et al.  Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. , 2000, AJR. American journal of roentgenology.

[23]  M. Graham.  Predicting radiation response. , 1997, International journal of radiation oncology, biology, physics.

[24]  J P Logue,et al.  Clinical variability of target volume description in conformal radiotherapy planning. , 1998, International journal of radiation oncology, biology, physics.

[25]  C. Ling,et al.  Technical aspects of the deep inspiration breath-hold technique in the treatment of thoracic cancer. , 2000, International journal of radiation oncology, biology, physics.

[26]  P. Boiselle.  MR imaging of thoracic lymph nodes. A comparison of computed tomography and positron emission tomography. , 2000, Magnetic resonance imaging clinics of North America.

[27]  Richard P. Baum,et al.  Image fusion of F-18 FDG pet and CT.- is there a role in 3D-radiation treatment planning of non-small cell lung cancer? , 2000 .

[28]  T K Lewellen,et al.  PET imaging using dual-headed gamma cameras: an update. , 1999, Nuclear medicine communications.

[29]  C B Caldwell,et al.  Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: the impact of 18FDG-hybrid PET fusion. , 2001, International journal of radiation oncology, biology, physics.

[30]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[31]  J. Deslauriers,et al.  Clinical and surgical staging of non-small cell lung cancer. , 2000, Chest.

[32]  W. Stanford,et al.  Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. , 1990, International journal of radiation oncology, biology, physics.

[33]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[34]  H Shirato,et al.  Impact of respiratory movement on the computed tomographic images of small lung tumors in three-dimensional (3D) radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[35]  S U Berlangieri,et al.  The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. , 1998, Lung cancer.

[36]  S Senan,et al.  Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.